ns' Numenta "HTM" system 111B061 I, Itatnar Arel's DeSTIN 1ARC09a1, Itamar Arel's HDRN 2 system (the proprietary, closed-source sibling of DeSTIN), Dileep George's spin-off from Numenta a, and work by Mo- hamad Tarifi 1TSH Ill, Bundzel and Hashimoto 11311101, and others. CSDLNs are reasonably well proven as an